CClinicalTrials.gg
CompletedNCT07384247DNUpdated Feb 3, 2026

Trigger Point Dry Needling With and Without Electrical Stimulation in Healthy Subjects

An interventional study of Dry needling with electrical stimulation and Dry needling in People With Identified Painful Trigger Points (Tp) Within the Soleus and Gastrocnemius Muscles Complex and Healthy Subjects or Volunteers, sponsored by University of Rhode Island. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-03.

Sponsored by University of Rhode Island · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 11 months after the study started (first participant enrolled Jan 2023, registered Dec 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 55 Years
Sex
All
01

Study summary

DN is one of the most commonly used physical therapy (PT) interventions for managing trigger points (Tp). Evidence suggests that DN was equally effective as other PT interventions, compared to no treatment or Sham-DN. Electrical stimulation (ES) is also a commonly used non-invasive method for pain management during PT. Recently, several studies suggested that combining DN with ES may be more effective in trigger point release than DN alone. The goal of this clinical trial was to determine the effects that trigger point dry needling with and without electrical stimulation had on pain threshold. It would also learn about the effect the trigger point dry needling has on muscle activity in people with identified painful trigger points within the soleus and gastrocnemius muscle complex. The main questions it aims to answer are:

  • In terms of trigger point pain threshold, is DN combined with ES superior to DN alone, ES alone, or Sham treatment?
  • In terms of muscle activity, is DN with ES superior to DN only, ES only or Sham treatment? Researchers will compare dry needling with electrical stimulation, dry needling only, electrical stimulation only and a Sham treatment to see these interventions affect pain threshold and muscle activity.

Participants will:

  • Randomly assigned as one of the four groups
  • Visit the clinic once for test
  • Receive permission and conduct intervention according to protocol.
02

Conditions studied

  • People With Identified Painful Trigger Points (Tp) Within the Soleus and Gastrocnemius Muscles Complex
  • Healthy Subjects or Volunteers

Browse trials for

Keywords

  • dry needling
  • electrical stimulation
  • H-reflex
  • motor activity
  • pain threshold
  • trigger point
03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's enrollment of 40 is below the median of 60 across 2,118 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

University of Rhode Island is the lead sponsor of 34 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: healthy volunteers with at least 2 ≥ identifiable trigger points in soleus or gastrocnemius

Exclusion Criteria:

Age \< 18 or > 55, able to communicate in English, no medical illness, or allergies

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Healthy subjects who has identified painful trigger points within the soleus and gastrocnemius.

    This study was a randomized controlled trial. Forty volunteers, aged 18-55 were recruited, signed an informed consent and randomly placed in four equal groups: dry needling with simultaneous electrical stimulation, dry needling only, electrical stimulation only, and a Sham treatment.

    Procedure: Dry needling with electrical stimulation · Procedure: Dry needling · Procedure: Electrical stimulation · Procedure: Sham

Interventions

  • ProcedureDry needling with electrical stimulation

    A dry needle inserted into the trigger point and left in the muscle for 10 min. Also, parameters of electrical stimulation were set at a frequency of 30 Hz and a pulse width of 0.6 ms, at an intensity that caused a small muscle contraction.

    Also known as: electrical dry needling

  • ProcedureDry needling

    A dry needle inserted into the trigger point and left in the muscle for 10 min. To ensure uniformity in conditions across all groups, a placebo electrical stimulation protocol was implemented, characterized by the initiation of electrical stimulation followed by its immediate cessation.

    Also known as: trigger point dry needling, acupuncture

  • ProcedureElectrical stimulation

    Electrical stimulation setting is same as above dry needling with electrical stimulation group while the needle touch the skin to cause a prick over the muscle and were held there for 10 min.

    Also known as: electrotherapy, electrostimulation, electrical muscle stimulation, neuromuscular electrical stimulation, transcutaneous electrical nerve stimulation (TENS)

  • ProcedureSham

    The needle touches the skin to cause a prick over the muscle and were held there for 10 min (placebo dry needling) with placebo electrical stimulation which means initiating electrical stimulation but removing it instantaneously.

    Also known as: placebo

06

What researchers measure

Primary outcomes

  1. To determine the effects that trigger point dry needling with and without electrical stimulation has on pain threshold

    Primary outcome measure: when subjects perceived the intensity to be 50% of their maximum pain, based on a 1-10 analog pain scale. Participants held a switch with a button connected to a Bluetooth-enabled PS 850 Data Log (Biometrics Ltd., UK) data acquisition software system, where all pain recordings were analyzed and stored. The pain threshold was measured three times and averaged. We also checked visual analogue scale (VAS).

    Time frame: This was a single time point study. Pain threshold was assessed before (baseline) and at 10 and 30 mins post treatment.

Other outcomes

  1. To investigate the effects that trigger point dry needling with and without electrical stimulation has on the muscle activity (H-reflex) within the soleus and gastrocnemius muscles

    Other outcome measure: Muscle activity was assessed using the H-reflex technique when the H-reflex amplitude was 15-25% of Mmax (H25%). Surface electrodes were used to stimulate the tibial nerve and record the H-reflex data. The H-reflex was elicited by a 2.5 cm monopolar stimulating ball electrode placed on the skin over the tibial nerve in the popliteal fossa. Ten Mmax responses were recorded. The electrical intensity was then lowered such that the H-reflex amplitude was 15-25% of Mmax (H25%). Ten H25% responses were recorded, and their averages served as the baseline data.

    Time frame: This was a single time point study. Muscle activity was assessed before (baseline) and at 10 and 30 mins post treatment.

07

Study locations

1 site
  • Doctor of Physical Therapy, University of Rhode Island
    Kingston, Rhode Island 02881, United States
08

References and documents

Individual participant data

Plan to share: No — This study was completed two years ago and received Institutional Review Board (IRB) approval; however, I require this approval for the submission of an original article.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07384247
Lead sponsor
University of Rhode Island
Responsible party
James Agostinucci (Associate Professor Sc.D., OTR/L, University of Rhode Island) — Principal investigator
First posted
Feb 3, 2026
Start date
Jan 2, 2023
Primary completion
Apr 20, 2023
Completion
Apr 30, 2023
Last update
Feb 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion